These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4127678)

  • 1. Letter: Pyrimethamine in central-nervous-system leukaemia.
    Carrera Boadella A; Pla Illa RP
    Lancet; 1973 Dec; 2(7841):1330. PubMed ID: 4127678
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrimethamine in central-nervous-system leukaemia.
    Price LA
    Lancet; 1973 Jun; 1(7815):1315. PubMed ID: 4126098
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyrimethamine in central-nervous-system leukaemia.
    Ragab AH
    Lancet; 1973 May; 1(7811):1061. PubMed ID: 4122138
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Pyrimethamine in prophylaxis of meningeal leukaemia.
    Hamers J; van Hove W; Baele G
    Lancet; 1974 Feb; 1(7852):310-1. PubMed ID: 4130488
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe megaloblastic anemia complicating pyrimethamine therapy.
    Chute JP; Decker CF; Cotelingam J
    Ann Intern Med; 1995 Jun; 122(11):884-5. PubMed ID: 7741386
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of CNS leukemia in childhood. An outline of current concepts.
    Pochedly C
    Clin Pediatr (Phila); 1972 Sep; 11(9):503-8. PubMed ID: 5073799
    [No Abstract]   [Full Text] [Related]  

  • 7. Long plasma half-life of pyrimethamine.
    Nichol CA
    Lancet; 1973 Jul; 2(7821):161. PubMed ID: 4124093
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukaemia in children.
    Malpas JS
    Br J Hosp Med; 1977 May; 17(5):444, 446-7, 449-50. PubMed ID: 266964
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of meningeal leukemia with pyrimethamine.
    Geils GF; Scott CW; Baugh CM; Butterworth
    Blood; 1971 Aug; 38(2):131-7. PubMed ID: 5283025
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute lymphoblastic leukaemia.
    Sinks LF
    Arch Dis Child; 1972 Oct; 47(255):811-3. PubMed ID: 4508181
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Leukaemia of the central nervous system.
    Reske-Nielsen E; Petersen JH; Sogaard H; Jensen KB
    Lancet; 1974 Feb; 1(7850):211-2. PubMed ID: 4129892
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Rose MS; Black PJ; Barkhan P
    Lancet; 1973 Mar; 1(7803):600. PubMed ID: 4120658
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Preventive central-nervous-system therapy in acute leukemia.
    Simone JV
    N Engl J Med; 1973 Dec; 289(23):1248-9. PubMed ID: 4800425
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose radiation therapy for leukemic involvement of the central nervous system.
    Cook JC; Considine B
    Radiology; 1972 Sep; 104(3):649-52. PubMed ID: 5068427
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics and intraventricular therapy with methotrexate via Ommaya reservoir for central nervous system leukemia (author's transl)].
    Fujimoto T; Sasaki K; Shingaki Y; Fukui M; Kitamura K
    Rinsho Ketsueki; 1980 Mar; 21(3):320-7. PubMed ID: 7411871
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Antimalarial drugs and Burkitt's lymphoma.
    Bruce-Chwatt LJ
    Lancet; 1974 Feb; 1(7850):223. PubMed ID: 4129915
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term follow up of central nervous system leukemia in children (author's transl)].
    Yokoyama T; Fujimoto T; Ito M; Furusho K; Kin H; Hasegawa A
    Rinsho Ketsueki; 1979 Mar; 20(3):246-52. PubMed ID: 439414
    [No Abstract]   [Full Text] [Related]  

  • 19. Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
    Sitarz AL; Albo V; Movassaghi N; Karon M; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(5):989-94. PubMed ID: 1106848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system leukemia.
    Bergevin PR
    N Y State J Med; 1975 Feb; 75(3):367-71. PubMed ID: 1094335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.